
    
      1. DA-2802 319mg Group: Administration with DA-2802 319mg tablet qd and placebo tablet
           matching to Viread® 300mg for 0-48 weeks.

        2. Viread® 300mg Group: Administration with Viread® 300mg tablet qd and placebo tablet
           matching to DA-2802 319mg for 0-48 weeks.
    
  